IBSA Institut Biochimique SA

Musculoskeletal Disorders

Clinical research in knee osteoarthritis with moderate to severe pain, focusing on pain relief and improved joint function.

  • Osteoarthritis-related pain
  • Functional impairment
  • Joint mobility

The sponsor’s activity in this area centers on therapies for degenerative joint disease and symptom control in adults affected by chronic joint discomfort.

Chondroitin Sulfate-Based Therapy

Research interest includes chondroitin sulfate formulations for the management of osteoarthritis, with attention to products derived from different natural sources.

  • Chondroitin sulfate tablets
  • Bovine-derived compounds
  • Marine-derived compounds

These studies reflect a therapeutic focus on cartilage-supporting agents used in chronic musculoskeletal care.

Topical Pain Management

Clinical work also covers lidocaine in a medicated plaster format, with attention to local tolerability and skin response in healthy volunteers.

  • Topical analgesia
  • Skin irritation
  • Sensitization potential

This area supports interest in localized pain treatment and transdermal delivery systems for dermatologic compatibility.

Dermal Tolerability and Safety

Research includes evaluation of cutaneous safety in healthy subjects, with emphasis on irritation and sensitization outcomes relevant to external-use products.

  • Healthy volunteer studies
  • Dermal compatibility
  • Local skin reactions

The sponsor’s portfolio in this domain is aligned with the assessment of topical pharmaceutical products intended for routine clinical use.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Comparison of bovine and marine chondroitin sulfate tablets (800 mg) in treating knee osteoarthritis pain and functional impairment

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Hungary Poland